Show MeYes, steroids can cause teeth problems, but almost always indirectly rather than by dissolving enamel. Glucocorticoids such as prednisone raise the risk of oral candidiasis, dry mouth, periodontal bone loss, impaired healing, and rare jaw osteonecrosis; anabolic steroids have far weaker dental evidence. The risk is dose- and duration-dependent, and it becomes clinically meaningful with prednisone doses at or above 2.5 mg per day for three months or longer, per the 2017 American College of Rheumatology glucocorticoid-induced osteoporosis guideline. Most patients on short courses do not develop permanent tooth damage.
Can Steroids Cause Teeth Problems? Mechanisms
The first mechanism is not erosion. Steroids do not chemically strip hydroxyapatite from enamel at normal oral pH. Caries needs acid, plaque, fermentable carbohydrate, and time; steroids matter because they change the immune response, saliva, bone remodeling, and tissue repair around that process.
Glucocorticoids bind receptors inside osteoblasts, osteocytes, and immune cells. At sustained prednisone-equivalent doses above 2.5 mg per day, bone formation markers such as P1NP can fall within one to three months. The same signaling shift increases RANKL relative to osteoprotegerin, so bone resorption outpaces replacement. In the jaw, that imbalance can make alveolar bone more vulnerable to periodontitis and slower to remodel after extraction or orthodontic movement.
Steroids also suppress local immunity. Inhaled corticosteroids deposit drug in the oropharynx, and roughly 1% to 5% of users develop oral candidiasis without mouth rinsing. Systemic glucocorticoids can produce broader immune suppression, but the exact dental infection rate depends on dose, duration, diabetes control, and concurrent immunosuppressants. In plain terms: the drug does not rot teeth directly; it weakens the body’s maintenance systems around them.
A third mechanism is mucosal and salivary change. Some steroid users report dry mouth, although objective salivary flow reductions are inconsistent across studies. Reduced saliva removes less acid and less debris, which raises caries risk when combined with high sugar intake or poor brushing. Steroids also impair collagen synthesis and wound contraction, so a dental extraction socket can heal more slowly.
Dose equivalence matters for comparing mechanisms. Prednisone 5 mg is roughly equivalent to prednisolone 5 mg, methylprednisolone 4 mg, and dexamethasone 0.75 mg. A patient taking dexamethasone 1.5 mg per day is therefore receiving about 10 mg of prednisone-equivalent exposure, not a trivial dose. That conversion explains why the same “steroid” label can carry very different dental risk.
Bone Effects That Reach the Jaw
Alveolar bone is not a passive socket. It turns over constantly in response to bite force, periodontal inflammation, and orthodontic load. Glucocorticoid-induced osteoporosis is a systemic disorder, but the jaw is exposed to the same osteoblast suppression and osteocyte apoptosis. Observational studies link chronic glucocorticoid use to roughly 1.5 to 2.5 times higher odds of periodontitis, although confounding by inflammatory disease is substantial.
Radiographic detection lags behind biology. Alveolar bone loss must usually reach 30% to 50% before it is clearly visible on plain films. A patient can therefore have active periodontal bone change with a seemingly stable X-ray. This is why clinical probing depth, bleeding on probing, and mobility matter more than a single panoramic image in steroid users.
Jaw osteonecrosis is the most feared bone effect, but it is uncommon with steroids alone. Most medication-related osteonecrosis cases involve high-dose antiresorptives such as zoledronic acid or denosumab, often combined with glucocorticoids. The 2022 American Association of Oral and Maxillofacial Surgeons position paper defines exposed bone or bone probed through a fistula for eight weeks or longer as the clinical threshold. Steroid-only cases are rare enough that absolute risk is not precisely estimated.
Bone loss also affects orthodontic mechanics. Tooth movement depends on controlled alveolar remodeling, and glucocorticoids may blunt that turnover. A typical orthodontic course runs 18 to 24 months; steroid-related slowing can extend treatment or increase relapse risk, but the evidence is low certainty. In plain terms: the jaw bone can become less responsive, not simply weaker.
Periodontal risk is amplified by diabetes and smoking. Steroid-induced hyperglycemia can push HbA1c above 7%, and smokers already have two to three times the periodontitis risk of nonsmokers. Those factors interact with steroid dose rather than acting independently. A 60-year-old on prednisone 10 mg per day who smokes has a very different dental trajectory from a 25-year-old on a five-day burst.
Quantified Dental Risk by Steroid Type and Dose
The dose thresholds need reconciliation. For bone risk, 2.5 mg per day of prednisone for three months is the guideline threshold; 7.5 mg per day for three months is a common high-risk cutoff in osteoporosis care; and 20 to 40 mg per day for one to two weeks is immunosuppressive but not equivalent to years of cumulative bone exposure. In other words, short high-dose bursts and long low-dose maintenance can both matter, but through different mechanisms.
| Steroid exposure | Typical dose or route | Main dental risk | Quantified context |
|---|---|---|---|
| Oral prednisone, long term | ≥2.5 mg/day for ≥3 months | Periodontal bone loss, caries risk, delayed healing | Bone formation markers can fall within 1–3 months |
| High-dose oral or IV pulse | 20–40 mg/day or 250–1,000 mg IV pulses | Oral candidiasis, impaired healing, rare osteonecrosis | Risk rises with cumulative dose and bisphosphonate co-use |
| Inhaled corticosteroid | Budesonide or fluticasone, 1–2 puffs daily | Local candidiasis, dysphonia | Oropharyngeal candidiasis in roughly 1–5% without rinsing |
| Nasal corticosteroid | 1–2 sprays daily | Minimal oral exposure | Low direct dental risk at standard doses |
| Anabolic-androgenic steroids | Testosterone or derivatives | Weak direct dental evidence | No robust caries or periodontitis odds ratio |
| Steroid plus antiresorptive | Prednisone plus zoledronic acid or denosumab | Medication-related osteonecrosis | Exposed bone ≥8 weeks is the clinical threshold |
The anabolic steroid row is important. Anabolic-androgenic steroids are not the same drug class as prednisone. They can cause dry mouth, gingival overgrowth, or cardiovascular effects in some users, but the dental literature is thin and inconsistent. Claims that anabolic steroids directly destroy teeth are not supported by strong clinical evidence. The stronger dental signal belongs to glucocorticoids, especially chronic oral therapy.
Inhaled steroids deserve separate attention because the risk is local. Rinsing with water and spitting after each inhalation reduces oropharyngeal deposition. A 2020 review of inhaled corticosteroid adverse effects found candidiasis and dysphonia among the most common local complaints, but serious dental destruction is not a typical outcome. The practical rule is mechanical removal, not fear of the inhaler.
Dental Timeline of Steroid Exposure
Steroid dental effects follow a time course, but not a single clock. Mucosal and immune changes can appear within weeks, bone formation changes within months, and cumulative periodontal damage over years. The table below separates what happens early from what becomes clinically visible later.
| Time window | Biologic or dental change | Clinical action |
|---|---|---|
| 0–72 hours | No enamel change; occasional mucosal irritation from inhaled drug | Rinse mouth after inhaled steroids; maintain brushing |
| 1–4 weeks | Immune suppression may allow oral candidiasis; extraction healing may slow | Inspect for white plaques, burning, or nonhealing sockets |
| 1–3 months | Bone formation markers can fall; dry mouth may worsen caries risk | Baseline dental exam if chronic therapy is planned |
| 3–12 months | Glucocorticoid-induced bone loss risk becomes measurable; periodontal inflammation may progress | Periodontal probing and radiographs as clinically indicated |
| 1–5 years | Cumulative caries, periodontitis, and rare osteonecrosis risk rise with total dose | Treat active dental disease before elective surgery |
| After discontinuation | Bone recovery is partial over 6–12 months; adrenal suppression can persist | Taper per prescriber; tell dentist about recent steroid use |
The 6–12 month recovery window is not a guarantee. Bone lost to periodontitis does not regrow reliably, and alveolar defects can persist. What recovers partially is systemic bone remodeling and adrenal function, not necessarily lost attachment. A patient who stops prednisone after five years still needs periodontal maintenance.
Adrenal suppression is a separate timeline issue. The 2016 Endocrine Society guideline notes that hypothalamic-pituitary-adrenal recovery after glucocorticoid therapy can take months and varies with dose and duration. For dental surgery, the question is not usually “will the tooth heal?” but “can the patient mount a stress cortisol response?” That is a medical management question, not a reason to avoid all dental care.
Edge Cases and Higher-Risk Patients
Children carry developing teeth and a growing jaw. Glucocorticoid exposure during enamel formation has been associated with enamel hypoplasia in observational studies, but causality is not proven. The window matters: primary teeth form in utero, and permanent incisors and first molars begin mineralizing around birth. A child on six months of prednisone for nephrotic syndrome deserves dental surveillance, but not a prediction of inevitable defects.
Orthodontic patients are another edge case. Alveolar bone remodeling is the engine of tooth movement, and steroid-related suppression can slow that engine. A 24-month treatment plan may run longer, and retainers matter more because relapse risk rises when bone turnover is low. The evidence does not support a precise percentage delay, so clinicians should monitor movement clinically rather than promise a fixed timeline.
Patients with diabetes have a compounded risk. Steroids raise blood glucose, and hyperglycemia impairs neutrophil function and collagen repair. An HbA1c above 7% before dental surgery predicts slower healing and more infection risk. The dental plan should include glycemic review, not just antibiotic prophylaxis.
Patients on bisphosphonates or denosumab are the highest osteonecrosis risk group. Adding glucocorticoids increases suppression of bone turnover and immune defense. The 2022 AAOMS position paper’s eight-week exposed-bone threshold is the red flag. A steroid user with a nonhealing extraction socket at eight weeks needs oral and maxillofacial evaluation, not another course of antibiotics alone.
Anabolic steroid users often fall outside medical monitoring. They may not disclose use to a dentist, and the dental evidence is weak. The real risks are cardiovascular, hematologic, and behavioral, plus possible xerostomia. A dentist should ask about all steroid forms, including inhaled, topical, injected, and nonprescribed anabolic products, without assuming the same mechanism.
Misconceptions and Evidence Limits
The most common misconception is that steroids dissolve enamel. Enamel dissolution requires acid challenge, typically below pH 5.5, and steroids do not create that acid directly. Steroids matter through saliva, plaque ecology, immunity, and bone. A patient who brushes twice daily with 1,000–1,500 ppm fluoride and limits sugar exposure retains substantial protection even on chronic prednisone.
A second misconception is that one short course causes cavities. A five-day prednisone burst for asthma or allergy does not measurably change caries risk in most patients. The clinical signal comes from months to years of exposure, especially at prednisone-equivalent doses above 2.5 mg per day. Short courses matter more for adrenal suppression and infection risk than for permanent tooth damage.
A third misconception is that all steroids are interchangeable. Prednisone, dexamethasone, inhaled budesonide, topical hydrocortisone, and testosterone derivatives have different routes, receptors, and risk profiles. The phrase “steroids cause teeth problems” is too broad to be clinically useful. The better question is which steroid, at what dose, by which route, for how long, and against what background risk.
Evidence limits are real. Most dental data on glucocorticoids are observational, drawn from patients with rheumatoid arthritis, lupus, inflammatory bowel disease, or transplanted organs. Those diseases themselves affect saliva, periodontitis, and healing. There are no long-term randomized trials of steroid dose versus tooth loss, and steroid-only jaw osteonecrosis is too rare for precise absolute risk estimates. Clinical caution should not become certainty.
What to Actually Do Before and During Steroid Therapy
Before starting prednisone at 2.5 mg per day or higher for three months or longer, get a dental exam and treat active caries or periodontitis. This is especially important before elective extractions or implant placement. The goal is to reduce the bacterial and inflammatory burden before immune suppression and bone suppression begin.
During therapy, keep the mouth mechanically clean. Brush twice daily with fluoride toothpaste, clean between teeth, and use sugar-free lozenges or sips of water for dry mouth. After inhaled steroids, rinse with water and spit rather than swallow. Do not stop steroids abruptly; taper according to the prescriber because adrenal suppression can last months.
Tell every dentist the exact steroid name, dose, route, start date, and whether bisphosphonates or denosumab are also used. Dental care is not contraindicated on steroids, but major surgery may require a stress-dose plan if adrenal suppression is suspected. For bone health, the 2017 ACR guideline supports calcium and vitamin D intake and bone density assessment in chronic glucocorticoid users.
Seek urgent dental review for these red flags:
- Exposed jaw bone or a socket that has not healed after eight weeks.
- Facial swelling with fever or pus, especially on steroids plus antiresorptives.
- New tooth mobility or a deep periodontal pocket that bleeds heavily.
- Trismus, numbness, or a nonhealing ulcer lasting more than two weeks.
- Uncontrolled bleeding after extraction or a procedure.
- Severe mouth pain with white plaques, suggesting oral candidiasis.
Finally, do not accept a blanket warning that steroids ruin teeth. The practical risk is a treatable mix of dry mouth, periodontal inflammation, delayed healing, and rare osteonecrosis. A dental exam before chronic therapy, mouth rinsing after inhaled drugs, and prompt review of nonhealing sites convert that risk into manageable care.